Selcuk Ecza Deposu Ticaret ve Sanayi AS
IST:SELEC.E

Watchlist Manager
Selcuk Ecza Deposu Ticaret ve Sanayi AS Logo
Selcuk Ecza Deposu Ticaret ve Sanayi AS
IST:SELEC.E
Watchlist
Price: 73 TRY 0.69%
Market Cap: 45.3B TRY

Selcuk Ecza Deposu Ticaret ve Sanayi AS
Change in Working Capital

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Selcuk Ecza Deposu Ticaret ve Sanayi AS
Change in Working Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Change in Working Capital CAGR 3Y CAGR 5Y CAGR 10Y
Selcuk Ecza Deposu Ticaret ve Sanayi AS
IST:SELEC.E
Change in Working Capital
-₺14.9B
CAGR 3-Years
-152%
CAGR 5-Years
-212%
CAGR 10-Years
N/A
No Stocks Found

Selcuk Ecza Deposu Ticaret ve Sanayi AS
Glance View

Market Cap
45.3B TRY
Industry
Health Care

In the dynamic landscape of Turkey's pharmaceutical industry, Selçuk Ecza Deposu Ticaret ve Sanayi A.Ş. stands as a formidable force, deftly operating as a bridge between pharmaceutical manufacturers and healthcare providers. Established in 1958, the company has cultivated an extensive distribution network that covers the length and breadth of Turkey. With a meticulously coordinated logistics framework, Selçuk Ecza ensures that a vast array of pharmaceutical products—from essential medicines to specialized healthcare solutions—reach pharmacies, hospitals, and healthcare institutions efficiently. This seamless operation is buoyed by the company’s ability to adapt to the ever-changing regulatory environment and consumer demands, thereby ensuring its relevance in the market for decades. The essence of Selçuk Ecza’s business model lies in its comprehensive approach to distribution, where it capitalizes on economies of scale to ensure cost-effectiveness while maintaining high-quality service standards. Revenue is generated primarily through the sales margins on the wide range of pharmaceuticals it distributes. The company’s proficiency in maintaining robust relationships with global pharmaceutical giants and local suppliers alike underpins its substantial market share. Furthermore, by embracing technological advancements, such as real-time inventory management systems, Selçuk Ecza optimizes its supply chain operations, minimizing delays and maximizing efficiency. This strategic prowess not only cements its position as a leading distributor in Turkey but also fosters sustainable growth by continuously aligning with the dynamic healthcare industry.

SELEC.E Intrinsic Value
117.67 TRY
Undervaluation 38%
Intrinsic Value
Price

See Also

What is Selcuk Ecza Deposu Ticaret ve Sanayi AS's Change in Working Capital?
Change in Working Capital
-14.9B TRY

Based on the financial report for Dec 31, 2024, Selcuk Ecza Deposu Ticaret ve Sanayi AS's Change in Working Capital amounts to -14.9B TRY.

What is Selcuk Ecza Deposu Ticaret ve Sanayi AS's Change in Working Capital growth rate?
Change in Working Capital CAGR 5Y
-212%

Over the last year, the Change in Working Capital growth was -2 611%. The average annual Change in Working Capital growth rates for Selcuk Ecza Deposu Ticaret ve Sanayi AS have been -152% over the past three years , -212% over the past five years .

Back to Top